These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8986454)

  • 1. Chronic effect of beta-adrenoceptor blockade on plasma levels of brain natriuretic peptide during exercise in essential hypertension.
    Tanaka M; Ishizaka Y; Ishiyama Y; Kato J; Kida O; Kitamura K; Kangawa K; Eto T
    Hypertens Res; 1996 Dec; 19(4):239-45. PubMed ID: 8986454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise-induced secretion of brain natriuretic peptide in essential hypertension and normal subjects.
    Tanaka M; Ishizaka Y; Ishiyama Y; Kato J; Kida O; Kitamura K; Kangawa K; Matsuo H; Eto T
    Hypertens Res; 1995 Jun; 18(2):159-66. PubMed ID: 7584923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.
    Nishikimi T; Yoshihara F; Morimoto A; Ishikawa K; Ishimitsu T; Saito Y; Kangawa K; Matsuo H; Omae T; Matsuoka H
    Hypertension; 1996 Jul; 28(1):22-30. PubMed ID: 8675258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial and brain natriuretic peptides: secretion during exercise in patients with essential hypertension and modulation by acute angiotensin-converting enzyme inhibition.
    Kohno M; Horio T; Yokokawa K; Murakawa K; Yasunari K; Kurihara N; Takeda T
    Clin Exp Pharmacol Physiol; 1992 Mar; 19(3):193-200. PubMed ID: 1387838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenoceptor blockade potentiates acute exercise-induced release of atrial natriuretic peptide by increasing atrial diameter in normotensive healthy subjects.
    Berlin I; Lechat P; Deray G; Landault C; Maistre G; Chermat V; Brouard R; Ressayre C; Puech AJ
    Eur J Clin Pharmacol; 1993; 44(2):127-33. PubMed ID: 8095894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between the antihypertensive effects of bisoprolol and levels of plasma atrial natriuretic peptide in hypertensive patients.
    Baláti B; Phung H; Pousset F; Isnard R; Boisvieux A; Carayon A; Komajda M; Lechat P
    Fundam Clin Pharmacol; 2002 Oct; 16(5):361-8. PubMed ID: 12602461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of beta 1-adrenoceptor blockade on plasma levels of atrial natriuretic peptide during exercise in normal man.
    Thamsborg G; Sykulski R; Larsen J; Storm T; Keller N
    Clin Physiol; 1987 Aug; 7(4):313-8. PubMed ID: 2887332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of beta-adrenergic blockade on plasma levels of atrial natriuretic peptide during exercise in humans.
    Tsai RC; Yamaji T; Ishibashi M; Takaku F; Hsu ST; Lai CY; Yeh SJ; Hung JS; Wu DL; Lee YS
    J Cardiovasc Pharmacol; 1988 May; 11(5):614-8. PubMed ID: 2455849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
    Wegner M; Ganten D; Stasch JP
    Hypertens Res; 1996 Dec; 19(4):229-38. PubMed ID: 8986453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different secretion patterns of adrenomedullin, brain natriuretic peptide, and atrial natriuretic peptide during exercise in hypertensive and normotensive subjects.
    Nishikimi T; Morimoto A; Ishikawa K; Saito Y; Kangawa K; Matsuo H; Kitamura K; Takishita S; Matsuoka H
    Clin Exp Hypertens; 1997 May; 19(4):503-18. PubMed ID: 9140711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the beta 1-blocker/beta 2-agonist celiprolol on atrial natriuretic peptide plasma levels in hypertensive patients.
    Papadopoulos CL; Kokkas B; Kotridis P; Karamouzis M; Haldoupi M; Platis A; Dadoush G; Kanonidis I
    Cardiovasc Drugs Ther; 1998 Sep; 12(4):345-6. PubMed ID: 9825178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation.
    Engelmann MD; Niemann L; Kanstrup IL; Skagen K; Godtfredsen J
    Int J Cardiol; 2005 Oct; 105(1):31-9. PubMed ID: 16207542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exaggerated secretion of atrial natriuretic polypeptide during dynamic exercise in patients with essential hypertension.
    Saito Y; Nakao K; Sugawara A; Nishimura K; Morii N; Yamada T; Itoh H; Shiono S; Mukoyama M; Arai H
    Am Heart J; 1988 Oct; 116(4):1052-7. PubMed ID: 2972180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of carvedilol on atrial natriuretic peptide, catecholamines, and hemodynamics in hypertension at rest and during exercise.
    Omvik P; Lund-Johansen P; Myking O
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S90-6. PubMed ID: 1378157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation.
    Wozakowska-Kapłon B; Opolski G
    Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.
    Irzmański R; Banach M; Piechota M; Kowalski J; Barylski M; Cierniewski C; Pawlicki L
    Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial natriuretic peptide and antihypertensive action due to beta-blockade in essential hypertensive patients.
    Hama J; Nagata S; Takenaka T; Kino H; Kamoi K; Shimada S; Horiuchi M; Katori R
    Angiology; 1995 Jun; 46(6):511-6. PubMed ID: 7785793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tertatolol potentiates exercise-induced atrial natriuretic peptide release by increasing atrial diameter in healthy subjects.
    Berlin I; Deray G; Lechat P; Maistre G; Landault C; Chermat V; Brouard R; Ressayre C; Puech AJ
    Cardiology; 1993; 83 Suppl 1():16-24. PubMed ID: 7903211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic peptide and brain natriuretic peptide release in human essential hypertension.
    Soualmia H; Ayadi I; Omar S; Feki M; Drissa H; Mebazaa A; Kaabachi N
    Clin Lab; 2009; 55(3-4):120-7. PubMed ID: 19462934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenoceptor antagonist propranolol potentiates hypotensive action of natriuretic peptides.
    Yoshimoto T; Naruse M; Irie K; Tanabe A; Seki T; Tanaka M; Imaki T; Naruse K; Muraki T; Matsuda Y; Demura H
    Eur J Pharmacol; 1998 Jun; 351(1):61-6. PubMed ID: 9698206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.